While the factors behind these population-level differences are unknown, a nephropathy-associated variant in APOL1 modifies the HDLc-eGFR association in African Americans with a strong inverse association observed in those with the risk genotype, while no association was observed among those without the risk genotype. This evidence concerns the gene APOL1 and kidney disorder.